BioNeutra isomalto-oligosaccharides in new food categories and in food supplements up to 10 g/day (over 10 years of age): isomaltose + DP3–DP9 ≥ 90 % DM, glucose ≤ 5 %, new microbiological criteria (total aerobic count ≤ 1000 CFU/g, E. coli absent in 10 g, Salmonella absent in 25 g); EFSA — two in-house HPLC-RI methods, because there are no standards

Commission Implementing Regulation (EU) 2025/97, published on 22 January 2025, adds to the Union list of novel foods a separate entry for the isomalto-oligosaccharides of BioNeutra North America Inc. (Edmonton, Canada), with new uses in more than a dozen food categories and in food supplements. Isomalto-oligosaccharides had already been authorised by a decision of the UK authority in 2016; those conditions of use apply to everyone, while the new ones apply for 5 years, until 11 February 2030, only to the applicant (data protection). The basis is the EFSA opinion of 14 December 2023.

Source: Rozporządzenie wykonawcze Komisji (UE) 2025/97 z dnia 21 stycznia 2025 r. zmieniające rozporządzenie wykonawcze (UE) 2017/2470 w odniesieniu do warunków stosowania i specyfikacji nowej żywności izomaltooligosacharydy

Lab-News